Also mentions Compliance:
Since Lehman's Collapse, Companies More Forthcoming on Compliance
x hide permanently

MiMedx Adds Luis A. Aguilar To Its Board Of Directors


MiMedx Group, Inc., the leading regenerative medicine and biopharmaceutical company utilizing human placental tissue allografts and patent-protected processes to develop and market advanced products and therapies for multiple sectors of healthcare, announced today its Board of Directors has appointed Luis A. Aguilar, former Commissioner of the U.S. Securities and Exchange Commission and highly accomplished lawyer within industry and private law practice, as an independent, non-employee Director of the MiMedx Board of Directors...

Mentions: Compliance Annual Meeting Board of Directors